Final-Program-ATS-2023-AP.vp

104

SUNDAY • MAY 21

12:00 Rare Variant Analysis in Non-Group 1 Pulmonary Hypertension M. Aldred, PhD, ATSF, Indianapolis, IN 12:15 The Effect of Pollution on Pulmonary Vascular Disease, Right Ventricular Function and HRQL in the PVDOMICS Cohort C. Lim, PhD, Tucson, United States 12:30 Metabolic Evolution Precedes PAH Diagnosis in Scleroderma: Insights from PVDOMICS and the Johns Hopkins Scleroderma Centerr C. Simpson, MD, Baltimore, MD 12:45 Genomics Analysis of mRNA in Peripheral Venous Blood Leukocytes for Identification of Clusters Across WSPH Groups and Associations with Severe or Mild G. Grunig, DVM, PhD, New York, NY NATIONAL AERONAUTICS AND SPACE ADMINISTRATION OUTSIDE ORGANIZATION SESSION ADVANTAGES OF NASA SATELLITE DATA IN AIR QUALITY AND RESPIRATORY HEALTH APPLICATIONS 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 147 A-B (Street Level) Target Audience Physicians; nurses; allied health professionals; public health practitioners; community health educators; researchers who are interested in using Earth observation data for environmental and occupational health research applications Objectives At the conclusion of this session, the participant will be able to: • provide an overview of the NASA Health and Air Quality Program activities that are of interest to clinicians and researchers. • analyze at least three cross-cutting applications where NASA satellite data can strengthen scientific understanding of the global health risk of air pollution. • inform clinicians and researchers about the PAHO/WHO experiences fostering integrative air quality monitoring as well as training opportunities in applying satellite data for health and air quality topics. NASA Earth-observing satellites offer real-time data about natural and anthropogenic processes within atmospheric, aquatic, and terrestrial ecosystems. These data, which complement ongoing epidemiological surveillance programs, provide health leaders with valuable insight on the spatial and temporal variation of health risks attributed to harmful exposure to poor air quality. In this session, panelists will demonstrate how NASA satellite data can strengthen health applications related to air quality and respiratory health with community decision-makers. L4

Panelists will share ongoing NASA projects that apply satellite data to quantify health risks associated with exposure to urban ambient pollution to enhance clinical practice and policy decision-making. Chairing: H. Chapman, MD, PhD, MPH, Washington, DC L. Judd, PhD, Hampton, VA 12:00 NASA Health and Air Quality Applications: Applying Satellite Data to Respiratory Hea J. Haynes, MS, WASHINGTION, DC 12:15 Advancing Air Quality Monitoring and Health Surveillance in the Americas J. Castillo, MSc, Washington, DC 12:30 The Impacts of Drought on Respiratory Health: Using NASA Data Products to Understand these Connections J. Bell, PhD, Omaha, NE 12:45 NASA Applied Remote Sensing Training (ARSET) for CUTTING EDGE IN TRANSLATION - NHLBI CATALYZE PROGRAM 12:00 PM - 1:00 PM Walter E. Washington Convention Center Room 204 A-C (Level 2) Target Audience Providers of lung health, investigators in lung physiology and pathophysiology, specific patient group or multiple groups Objectives At the conclusion of this session, the participant will be able to: • to learn about the NHLBI Catalyze Program and Objectives • improve NHLBI catalyze program pipeline and success rate • learn emerging technologies and therapeutics for the treatment/management of respiratory diseases The NHLBI Catalyze Program provides a comprehensive suite of support and services to facilitate the translation of basic scientific discoveries into viable therapeutics, devices, and diagnostics ready for human testing. Currently, the Catalyze Program supports five funding opportunities with different funding mechanisms, budget limits, cost sharing requirements, application materials, and project periods. The Catalyze program have funded 14 awards in lung or lung related research areas, ranging from device, imaging technique, small molecules to biologics on a variety of lung diseases, acute or chronic. ATS noon session will be a good opportunity to highlight/showcase catalyze program and to advocate the cutting edge translational effort in NHLBI/DLD mission space. Health and Air Quality Applications M. Follette Cook, PhD, Greenbelt, MD DIVISION OF LUNG DISEASES, NHLBI/NIH OUTSIDE ORGANIZATION SESSION L5

ATS 2023 • Washington, DC